DK1330293T4 - Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf - Google Patents

Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1330293T4
Authority: DK; Denmark
Prior art keywords: preparation; lactic acid; controlled release; acid polymer; release preparation
Prior art date: 2001-06-29

Application number

DK02738838.8T

Other languages

English (en)

Other versions

DK1330293T3 (da

Inventor

Kazumichi Yamamoto

Akiko Yamada

Yoshio Hata

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-29

Filing date

2002-06-28

Publication date

2011-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26617910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1330293(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-06-28 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2006-09-11 Application granted granted Critical

2006-09-11 Publication of DK1330293T3 publication Critical patent/DK1330293T3/da

2011-01-10 Publication of DK1330293T4 publication Critical patent/DK1330293T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Gynecology & Obstetrics (AREA)
Neurology (AREA)
Zoology (AREA)
Pregnancy & Childbirth (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK02738838.8T 2001-06-29 2002-06-28 Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf DK1330293T4 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001199484		2001-06-29
JP2001340993		2001-11-06
PCT/JP2002/006527 WO2003002092A2 (en)	2001-06-29	2002-06-28	Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same

Publications (2)

Publication Number	Publication Date
DK1330293T3 DK1330293T3 (da)	2006-09-11
DK1330293T4 true DK1330293T4 (da)	2011-01-10

Family

ID=26617910

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02738838.8T DK1330293T4 (da)	2001-06-29	2002-06-28	Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf
DK08003261.8T DK1949936T3 (da)	2001-06-29	2002-06-28	Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK08003261.8T DK1949936T3 (da)	2001-06-29	2002-06-28	Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf

Country Status (33)

Country	Link
US (4)	US7429559B2 (da)
EP (3)	EP1330293B2 (da)
JP (5)	JP2003206240A (da)
KR (2)	KR100961413B1 (da)
CN (3)	CN1292796C (da)
AR (2)	AR034641A1 (da)
AT (3)	ATE509668T1 (da)
AU (2)	AU2002311631B2 (da)
BR (1)	BRPI0210561B8 (da)
CA (1)	CA2455392C (da)
CO (1)	CO5540367A2 (da)
CR (1)	CR11283A (da)
CY (2)	CY1105071T1 (da)
CZ (1)	CZ306327B6 (da)
DE (2)	DE60225481T2 (da)
DK (2)	DK1330293T4 (da)
ES (2)	ES2366677T3 (da)
HU (1)	HU230351B1 (da)
IL (3)	IL159059A0 (da)
MX (1)	MXPA03011456A (da)
MY (1)	MY142066A (da)
NO (1)	NO331883B1 (da)
NZ (2)	NZ541884A (da)
PE (1)	PE20030066A1 (da)
PL (1)	PL204903B1 (da)
PT (2)	PT1949936E (da)
RU (1)	RU2301661C2 (da)
SG (1)	SG180015A1 (da)
SI (1)	SI1949936T1 (da)
SK (1)	SK287577B6 (da)
TW (2)	TW200526267A (da)
WO (1)	WO2003002092A2 (da)
ZA (1)	ZA200309152B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU758596B2 (en)	1998-01-16	2003-03-27	Takeda Pharmaceutical Company Limited	Sustained release compositions, process for producing the same and utilization thereof
TWI225416B (en) *	2001-06-29	2004-12-21	Takeda Chemical Industries Ltd	Sustained-release composition and process for producing the same
TW200526267A (en) *	2001-06-29	2005-08-16	Takeda Chemical Industries Ltd	Controlled release composition and method of producing the same
PT1532985T (pt) *	2002-06-25	2017-01-20	Takeda Pharmaceuticals Co	Processo de produção de uma composição de libertação sustentada
CN102166192B (zh)	2003-04-10	2013-09-25	Pr药品有限公司	一种用于生产基于乳化的微观粒子的方法
US20070207211A1 (en) *	2003-04-10	2007-09-06	Pr Pharmaceuticals, Inc.	Emulsion-based microparticles and methods for the production thereof
CA2532302C (en) *	2003-07-15	2016-12-20	Pr Pharmaceuticals, Inc.	Method for the preparation of controlled release formulations
JP5165240B2 (ja) *	2003-07-23	2013-03-21	ピーアールファーマシューティカルズ，インコーポレイテッド	徐放組成物
TW200529890A (en)	2004-02-10	2005-09-16	Takeda Pharmaceutical	Sustained-release preparations
TW200613012A (en) *	2004-07-02	2006-05-01	Takeda Pharmaceuticals Co	Sustained-release composition, process for producing the same and use of the same
US20060251581A1 (en) *	2005-05-09	2006-11-09	Mcintyre Jon T	Method for treatment of uterine fibroid tumors
WO2007070563A2 (en) *	2005-12-13	2007-06-21	Harkness Pharmaceuticals, Inc.	Stable solid forms of enterostatin
RU2427383C2 (ru)	2006-01-18	2011-08-27	КьюПиЭс, ЭлЭлСи	Фармацевтические композиции с повышенной стабильностью
US7858663B1 (en) *	2007-10-31	2010-12-28	Pisgah Laboratories, Inc.	Physical and chemical properties of thyroid hormone organic acid addition salts
NO347209B1 (no)	2006-12-18	2023-07-03	Takeda Pharmaceutical	Sammensetning med forlenget frigjøring og fremgangsmåte for å produsere det samme
US20110319987A1 (en) *	2009-05-20	2011-12-29	Arsenal Medical	Medical implant
KR101811797B1 (ko) *	2013-04-03	2017-12-22	동국제약 주식회사	도네페질을 포함하는 비경구투여용 약제학적 조성물
CN105764491A (zh)	2013-12-09	2016-07-13	度瑞公司	药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
CN103751851A (zh) *	2014-01-17	2014-04-30	东华大学	一种无机/有机多药物控释复合纳米纤维支架的制备方法
KR101558083B1 (ko) *	2014-04-07	2015-10-07	에스케이케미칼주식회사	약물함유 고분자미립구 제조방법
US9956164B2 (en)	2014-04-16	2018-05-01	Veyx-Pharma Gmbh	Veterinary pharmaceutical composition and use thereof
US10787920B2 (en)	2016-10-12	2020-09-29	General Electric Company	Turbine engine inducer assembly
KR102089737B1 (ko) *	2017-11-01	2020-03-16	한국화학연구원	에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
WO2024095158A1 (en)	2022-10-31	2024-05-10	Takeda Pharmaceutical Company Limited	Dosing of orexin type 2 receptor agonists
WO2025229493A1 (en)	2024-04-29	2025-11-06	Takeda Pharmaceutical Company Limited	Dosing of orexin type 2 receptor agonists
WO2025229492A1 (en)	2024-04-29	2025-11-06	Takeda Pharmaceutical Company Limited	Orexin type 2 receptor agonist microcapsules for sustained release dosing

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3297033A (en) *	1963-10-31	1967-01-10	American Cyanamid Co	Surgical sutures
US3565869A (en) *	1968-12-23	1971-02-23	American Cyanamid Co	Extrudable and stretchable polyglycolic acid and process for preparing same
US3773919A (en) *	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
US3755558A (en) *	1971-02-23	1973-08-28	Du Pont	Polylactide drug mixtures for topical application atelet aggregation
US3839297A (en) *	1971-11-22	1974-10-01	Ethicon Inc	Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US3912692A (en) *	1973-05-03	1975-10-14	American Cyanamid Co	Process for polymerizing a substantially pure glycolide composition
US3890283A (en) *	1973-06-04	1975-06-17	American Cyanamid Co	Process for post-polymerizing polyglycolic acid
US4258063A (en)	1978-06-23	1981-03-24	Henkel Corporation	Self-emulsifying cosmetic base
US4249531A (en) *	1979-07-05	1981-02-10	Alza Corporation	Bioerodible system for delivering drug manufactured from poly(carboxylic acid)
US4273920A (en) *	1979-09-12	1981-06-16	Eli Lilly And Company	Polymerization process and product
PH19942A (en)	1980-11-18	1986-08-14	Sintex Inc	Microencapsulation of water soluble polypeptides
IE52535B1 (en) *	1981-02-16	1987-12-09	Ici Plc	Continuous release pharmaceutical compositions
US4479911A (en) *	1982-01-28	1984-10-30	Sandoz, Inc.	Process for preparation of microspheres and modification of release rate of core material
US4605730A (en) *	1982-10-01	1986-08-12	Ethicon, Inc.	Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4539981A (en) *	1982-11-08	1985-09-10	Johnson & Johnson Products, Inc.	Absorbable bone fixation device
FR2537980B1 (fr) *	1982-12-17	1986-12-19	Sandoz Sa	Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
CH656884A5 (de)	1983-08-26	1986-07-31	Sandoz Ag	Polyolester, deren herstellung und verwendung.
JPS60100516A (ja) *	1983-11-04	1985-06-04	Takeda Chem Ind Ltd	徐放型マイクロカプセルの製造法
JPH0678425B2 (ja)	1984-07-06	1994-10-05	和光純薬工業株式会社	重合体の新規製造法
CA1236641A (en) *	1984-07-06	1988-05-10	Motoaki Tanaka	Copolymer of lactic acid and glycolic acid and method for producing same
ATE61935T1 (de)	1985-02-07	1991-04-15	Takeda Chemical Industries Ltd	Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) †	1985-05-07	1996-11-06	武田薬品工業株式会社	ポリオキシカルボン酸エステルおよびその製造法
ATE168391T1 (de) *	1990-04-13	1998-08-15	Takeda Chemical Industries Ltd	Biologisch abbaubare hochmolekulare polymere, ihre herstellung und ihre verwendung
JP3277342B2 (ja)	1992-09-02	2002-04-22	武田薬品工業株式会社	徐放性マイクロカプセルの製造法
US5353086A (en) *	1993-05-03	1994-10-04	Eastman Kodak Company	Textured surface with canted channels for an automatic tray processor
DE4342092B4 (de) *	1993-12-09	2007-01-11	Zentaris Gmbh	Langwirkende Injektionssuspension und Verfahren zur Herstellung
US5594091A (en) *	1994-02-21	1997-01-14	Takeda Chemical Industries, Ltd.	Matrix for sustained-release preparation
JP3490171B2 (ja)	1994-02-21	2004-01-26	武田薬品工業株式会社	生体内分解性ポリマーの末端カルボキシル基におけるエステル
US5763513A (en) *	1994-05-19	1998-06-09	Mitsui Toatsu Chemicals, Inc.	L-lactic acid polymer composition, molded product and film
JPH08259460A (ja) *	1995-01-23	1996-10-08	Takeda Chem Ind Ltd	徐放性製剤の製造法
JP3902272B2 (ja) *	1995-09-04	2007-04-04	武田薬品工業株式会社	徐放性製剤の製造法
US5922662A (en) *	1996-08-07	1999-07-13	Colgate Palmolive Company	High foaming nonionic surfactant based liquid detergent
ES2221019T3 (es)	1996-10-31	2004-12-16	Takeda Chemical Industries, Ltd.	Preparacion de liberacion mantenida.
AU5678398A (en)	1997-01-29	1998-08-18	Takeda Chemical Industries Ltd.	Sustained-release microspheres, their production and use
JPH10273447A (ja) *	1997-01-29	1998-10-13	Takeda Chem Ind Ltd	徐放性マイクロスフィア、その製造法および用途
AU758596B2 (en) *	1998-01-16	2003-03-27	Takeda Pharmaceutical Company Limited	Sustained release compositions, process for producing the same and utilization thereof
JPH11269094A (ja)	1998-01-16	1999-10-05	Takeda Chem Ind Ltd	徐放性組成物、その製造法および用途
US6114495A (en) *	1998-04-01	2000-09-05	Cargill Incorporated	Lactic acid residue containing polymer composition and product having improved stability, and method for preparation and use thereof
US6565874B1 (en) *	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
US6756472B1 (en) *	1998-12-15	2004-06-29	Takeda Chemical Industries, Ltd.	Process for producing polymer
JP2000238051A (ja) †	1999-02-23	2000-09-05	Kansei Corp	表皮シートの発泡成形型へのセッティング方法
JP2001081043A (ja) *	1999-07-15	2001-03-27	Takeda Chem Ind Ltd	徐放性組成物、その製造法および用途
RU2002103718A (ru)	1999-07-15	2003-10-10	Такеда Кемикал Индастриз, Лтд. (JP)	Композиции пролонгированного действия, способы их получения и применение
JP3837607B2 (ja) †	2000-05-29	2006-10-25	Ｔｃｍ株式会社	マスト用溶接位置決め治具
EP1693054B1 (en)	2000-08-07	2016-05-25	Wako Pure Chemical Industries, Ltd.	Lactic acid polymer and process for producing the same
AU2002218494A1 (en) *	2000-11-29	2002-06-11	Takeda Chemical Industries Ltd.	Medicinal compositions and process for producing the same
AU2002221139A1 (en) *	2000-12-15	2002-06-24	Takeda Chemical Industries Ltd.	Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
TW200526267A (en) *	2001-06-29	2005-08-16	Takeda Chemical Industries Ltd	Controlled release composition and method of producing the same

2002
- 2002-06-26 TW TW094113186A patent/TW200526267A/zh unknown
- 2002-06-26 AR ARP020102406A patent/AR034641A1/es not_active Application Discontinuation
- 2002-06-26 TW TW091114000A patent/TWI332407B/zh not_active IP Right Cessation
- 2002-06-27 PE PE2002000578A patent/PE20030066A1/es active IP Right Grant
- 2002-06-28 BR BR0210561-6 patent/BRPI0210561B8/pt not_active IP Right Cessation
- 2002-06-28 AU AU2002311631A patent/AU2002311631B2/en not_active Expired
- 2002-06-28 CA CA2455392A patent/CA2455392C/en not_active Expired - Fee Related
- 2002-06-28 ES ES08003261T patent/ES2366677T3/es not_active Expired - Lifetime
- 2002-06-28 RU RU2004102507/15A patent/RU2301661C2/ru active
- 2002-06-28 DK DK02738838.8T patent/DK1330293T4/da active
- 2002-06-28 NZ NZ541884A patent/NZ541884A/en not_active IP Right Cessation
- 2002-06-28 EP EP02738838A patent/EP1330293B2/en not_active Expired - Lifetime
- 2002-06-28 EP EP04076939A patent/EP1491236B1/en not_active Expired - Lifetime
- 2002-06-28 SK SK1560-2003A patent/SK287577B6/sk unknown
- 2002-06-28 IL IL15905902A patent/IL159059A0/xx unknown
- 2002-06-28 NZ NZ529969A patent/NZ529969A/en not_active IP Right Cessation
- 2002-06-28 CN CNB028130618A patent/CN1292796C/zh not_active Expired - Lifetime
- 2002-06-28 EP EP08003261A patent/EP1949936B1/en not_active Expired - Lifetime
- 2002-06-28 DE DE60225481T patent/DE60225481T2/de not_active Expired - Lifetime
- 2002-06-28 DK DK08003261.8T patent/DK1949936T3/da active
- 2002-06-28 DE DE60211464T patent/DE60211464T3/de not_active Expired - Lifetime
- 2002-06-28 PT PT08003261T patent/PT1949936E/pt unknown
- 2002-06-28 PT PT02738838T patent/PT1330293E/pt unknown
- 2002-06-28 SI SI200230949T patent/SI1949936T1/sl unknown
- 2002-06-28 ES ES02738838T patent/ES2263788T5/es not_active Expired - Lifetime
- 2002-06-28 MY MYPI20022474A patent/MY142066A/en unknown
- 2002-06-28 WO PCT/JP2002/006527 patent/WO2003002092A2/en not_active Ceased
- 2002-06-28 JP JP2002189247A patent/JP2003206240A/ja active Pending
- 2002-06-28 HU HU0400378A patent/HU230351B1/hu unknown
- 2002-06-28 AT AT08003261T patent/ATE509668T1/de active
- 2002-06-28 US US10/182,731 patent/US7429559B2/en not_active Expired - Fee Related
- 2002-06-28 KR KR1020097001485A patent/KR100961413B1/ko not_active Expired - Fee Related
- 2002-06-28 MX MXPA03011456A patent/MXPA03011456A/es active IP Right Grant
- 2002-06-28 KR KR1020037017129A patent/KR100916173B1/ko not_active Expired - Lifetime
- 2002-06-28 AT AT04076939T patent/ATE387937T1/de not_active IP Right Cessation
- 2002-06-28 SG SG2005085675A patent/SG180015A1/en unknown
- 2002-06-28 AT AT02738838T patent/ATE326264T1/de active
- 2002-06-28 CZ CZ2003-3493A patent/CZ306327B6/cs not_active IP Right Cessation
- 2002-06-28 PL PL367518A patent/PL204903B1/pl unknown
- 2002-06-28 CN CNB2005100896706A patent/CN100348265C/zh not_active Expired - Fee Related
- 2002-06-28 CN CN200610093268A patent/CN100577206C/zh not_active Expired - Fee Related
2003
- 2003-11-25 IL IL159059A patent/IL159059A/en active IP Right Grant
- 2003-11-25 ZA ZA2003/09152A patent/ZA200309152B/en unknown
- 2003-12-19 NO NO20035738A patent/NO331883B1/no not_active IP Right Cessation
- 2003-12-22 CO CO03111729A patent/CO5540367A2/es active IP Right Grant
2004
- 2004-04-13 JP JP2004117981A patent/JP2004238400A/ja not_active Withdrawn
2006
- 2006-07-07 CY CY20061100943T patent/CY1105071T1/el unknown
- 2006-12-01 AU AU2006246508A patent/AU2006246508B2/en not_active Ceased
2007
- 2007-10-18 IL IL186782A patent/IL186782A0/en unknown
2008
- 2008-07-29 US US12/181,472 patent/US8067030B2/en not_active Expired - Fee Related
2009
- 2009-03-18 JP JP2009065612A patent/JP2009167203A/ja not_active Withdrawn
2010
- 2010-02-18 CR CR11283A patent/CR11283A/es unknown
- 2010-04-26 JP JP2010101265A patent/JP4819173B2/ja not_active Expired - Lifetime
- 2010-04-26 JP JP2010101264A patent/JP4819172B2/ja not_active Expired - Lifetime
2011
- 2011-03-16 US US13/064,282 patent/US8246987B2/en not_active Expired - Fee Related
- 2011-07-15 CY CY20111100692T patent/CY1111708T1/el unknown
2012
- 2012-07-13 US US13/548,463 patent/US8815801B2/en not_active Expired - Lifetime
2014
- 2014-11-03 AR ARP140104096A patent/AR098261A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60225481D1 (de)	2008-04-17
MXPA03011456A (es)	2004-07-01
CA2455392C (en)	2011-11-22
SK287577B6 (sk)	2011-03-04
MY142066A (en)	2010-08-30
HUP0400378A2 (hu)	2004-12-28
ZA200309152B (en)	2005-01-26
PT1330293E (pt)	2006-08-31
CN1292796C (zh)	2007-01-03
CN1535168A (zh)	2004-10-06
PL204903B1 (pl)	2010-02-26
CN100577206C (zh)	2010-01-06
DE60211464D1 (de)	2006-06-22
EP1330293B1 (en)	2006-05-17
HK1056332A1 (en)	2004-02-13
ATE326264T1 (de)	2006-06-15
AU2006246508A1 (en)	2006-12-21
NO20035738D0 (no)	2003-12-19
BRPI0210561B1 (pt)	2018-08-14
WO2003002092A3 (en)	2003-04-10
US20030134800A1 (en)	2003-07-17
RU2301661C2 (ru)	2007-06-27
JP4819172B2 (ja)	2011-11-24
CR11283A (es)	2010-05-31
US8246987B2 (en)	2012-08-21
NZ529969A (en)	2005-10-28
DE60225481T2 (de)	2009-02-26
CA2455392A1 (en)	2003-01-09
ATE509668T1 (de)	2011-06-15
ES2366677T3 (es)	2011-10-24
KR20040018402A (ko)	2004-03-03
RU2004102507A (ru)	2005-03-10
CN1868458A (zh)	2006-11-29
WO2003002092A2 (en)	2003-01-09
US7429559B2 (en)	2008-09-30
ES2263788T5 (es)	2011-02-22
JP2010189428A (ja)	2010-09-02
CN1724066A (zh)	2006-01-25
JP4819173B2 (ja)	2011-11-24
HU230351B1 (hu)	2016-02-29
PT1949936E (pt)	2011-07-12
EP1491236B1 (en)	2008-03-05
DK1949936T3 (da)	2011-08-15
BRPI0210561B8 (pt)	2021-05-25
JP2004238400A (ja)	2004-08-26
PL367518A1 (pl)	2005-02-21
EP1949936A2 (en)	2008-07-30
NO20035738L (no)	2004-02-27
KR100961413B1 (ko)	2010-06-09
PE20030066A1 (es)	2003-03-20
AR098261A2 (es)	2016-05-18
CO5540367A2 (es)	2005-07-29
EP1491236A1 (en)	2004-12-29
TW200526267A (en)	2005-08-16
AU2002311631B2 (en)	2007-02-08
CY1111708T1 (el)	2015-10-07
US20090005318A1 (en)	2009-01-01
DE60211464T2 (de)	2006-09-07
TWI332407B (en)	2010-11-01
KR100916173B1 (ko)	2009-09-08
US20110166084A1 (en)	2011-07-07
DE60211464T3 (de)	2011-03-17
EP1330293B2 (en)	2010-10-27
US20120283187A1 (en)	2012-11-08
CZ306327B6 (cs)	2016-12-07
AR034641A1 (es)	2004-03-03
ATE387937T1 (de)	2008-03-15
CY1105071T1 (el)	2010-03-03
CN100348265C (zh)	2007-11-14
EP1949936A3 (en)	2008-10-08
EP1949936B1 (en)	2011-05-18
CZ20033493A3 (cs)	2004-08-18
US8815801B2 (en)	2014-08-26
KR20090020708A (ko)	2009-02-26
EP1330293A2 (en)	2003-07-30
JP2010189427A (ja)	2010-09-02
BR0210561A (pt)	2004-06-22
NO331883B1 (no)	2012-04-23
NZ541884A (en)	2007-01-26
SK15602003A3 (sk)	2004-06-08
DK1330293T3 (da)	2006-09-11
SG180015A1 (en)	2012-05-30
IL159059A (en)	2011-06-30
US8067030B2 (en)	2011-11-29
JP2003206240A (ja)	2003-07-22
JP2009167203A (ja)	2009-07-30
SI1949936T1 (sl)	2011-08-31
HUP0400378A3 (en)	2010-01-28
IL159059A0 (en)	2004-05-12
IL186782A0 (en)	2008-02-09
ES2263788T3 (es)	2006-12-16
AU2006246508B2 (en)	2008-09-04

Publication	Publication Date	Title
DK1330293T3 (da)	2006-09-11	Præparat til kontrolleret frigivelse omfattende mælkesyrepolymer og fremgangsmåde til fremstilling deraf
DK1399133T3 (da)	2009-08-03	Langvarig frigörelsessammensætning omfattende mælkesyre-glycolsyre copolymer og fremgangsmåde til fremstilling af disse
DK1180518T3 (da)	2007-05-21	5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
EP1832298A4 (en)	2012-12-12	MATRIX-TYPE-CONTROLLED RELEASE PREPARATION COMPRISING A BASIC SUBSTANCE OR SALT THEREOF AND PROCESS FOR PRODUCTION THEREOF
ATE322269T1 (de)	2006-04-15	Aripiprazole wirkstoff mit niedriger hygroskopie und verfahren zu ihrer herstellung
AR028387A1 (es)	2003-05-07	Forcps quirurgico miniaturizado y metodos para su produccion
IS7188A (is)	2004-03-18	Asabísýklísk-setin samtengd heteróarýl efnasambönd, aðferð til framleiðslu þeirra og notkun
DK1449917T3 (da)	2006-11-27	Fremgangsmåde til L-aminosyrefremstilling under anvendelse af Escherichia
DE60238439D1 (de)	2011-01-05	Wasserabsorbierende polymere und verfahren zu deren herstellung
IS6724A (is)	2003-02-20	Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra
NO20021736D0 (no)	2002-04-12	Nytt preparat og fremgangsmåte for stabilisering av det
DK1261697T3 (da)	2004-11-22	Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
DE60230949D1 (de)	2009-03-12	Heizung und Verfahren zu ihrer Herstellung
EP1450716A4 (en)	2010-11-10	METHOD AND SYSTEMS FOR THE PRODUCTION OF BLOOD PRECAUTIONS
AU2002331254A1 (en)	2003-03-03	Device and method for preparing blood
AU2003272341A1 (en)	2004-04-30	Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
DK1276760T3 (da)	2007-03-19	Polyamidnukleinsyrederivater, middel og fremgangsmåde til deres fremstilling
EP1660437A4 (en)	2006-09-20	Hydroxamic acid derivatives and process for their preparation
DK1627631T3 (da)	2012-04-30	Morfinsulfatmikrogranuler, fremgangsmåde til fremstilling deraf og præparat omfattende samme
ZA200308687B (en)	2004-11-23	Method and device for the two-step production of acrylic acid.
NO20013735D0 (no)	2001-07-30	Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
DE60109407D1 (de)	2005-04-21	Taumelscheibe und Verfahren zu ihrer Herstellung
NO20031844L (no)	2003-06-12	Nye askorbinsyreforbindelser, fremgangsmåter for fremstilling derav og anvendelse derav
NO20033120L (no)	2003-09-11	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
DK1282639T3 (da)	2005-12-12	Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf